Who makes alverine citrate, simeticone?

alverine citrate, simeticone is developed by Laboratoires Mayoly Spindler.

What development phase is alverine citrate, simeticone in?

alverine citrate, simeticone is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

alverine citrate, simeticone

Laboratoires Mayoly Spindler · FDA-approved active Small molecule Quality 5/100

At a glance

Generic name	alverine citrate, simeticone
Sponsor	Laboratoires Mayoly Spindler
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Carvedilol and Alverine in Portal Hypertension (PHASE2, PHASE3)
The Safety and Efficacy of Alverine in the Treatment of Cirrhotic Portal Hypertension (PHASE2, PHASE3)
The Efficacy and Safety of Alverine in the Treatment of Portal Hypertension in Patients With Liver Cirrhosis (PHASE2, PHASE3)
The Role of Irritable Bowel Syndrome in Lactose Intolerance (LION) (NA)
Combination of Alverine-simeticone and i3.1 Probiotic in IBS-D and IBS-M in Mexico (PHASE4)
Effectiveness of On-demand Meteospasmyl® Use in Irritable Bowel Syndrome (IBS) (PHASE4)
Efficacy and Safety of Meteospasmyl® in Irritable Bowel Syndrome (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

alverine citrate, simeticone CI brief — competitive landscape report
alverine citrate, simeticone updates RSS · CI watch RSS
Laboratoires Mayoly Spindler portfolio CI